Double-Blind Clinical Trial of Arginine Supplementation in the Treatment of Adult Patients with Sickle Cell Anaemia
Background. Sickle cell anaemia (SCA) is the most prevalent monogenic disease in Brazil. In SCA, haemoglobin S (HbS) is formed, which modifies red blood cell morphology. Intravascular haemolysis occurs, in which free Hb and free radicals degrade nitric oxide (NO) and release arginase, which reduces...
Auteurs principaux: | Renata M. N. Eleutério, Francisco O. Nascimento, Tamara G. Araújo, Marilena F. Castro, Tarcísio P. Almeida Filho, Pedro A. Maia Filho, José Eleutério, Darcielle B. D. Elias, Romélia P. G. Lemes |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Wiley
2019-01-01
|
Collection: | Advances in Hematology |
Accès en ligne: | http://dx.doi.org/10.1155/2019/4397150 |
Documents similaires
-
Cytotoxicity and DNA damage in the neutrophils of patients with sickle cell anaemia treated with hydroxyurea
par: Alano Martins Pedrosa, et autres
Publié: (2014-04-01) -
L-Arginine supplementation enhanced expression of glucose transporter (GLUT 1) in sickle cell anaemia subjects in the steady state
par: W.A. Saka, et autres
Publié: (2023-01-01) -
SICKLE CELL ANAEMIA AND MALARIA
par: Lucio Luzzatto
Publié: (2012-10-01) -
Ready-to-use food supplement, with or without arginine and citrulline, with daily chloroquine in Tanzanian children with sickle-cell disease: a double-blind, random order crossover trial
par: Cox, SE, et autres
Publié: (2018) -
Standardization method for measurement of hydroxyurea by Ultra High Efficiency Liquid Chromatography in plasma of patients with sickle cell disease
par: Darcielle Bruna Dias Elias, et autres
Publié: (2014-09-01)